Streetbeat News

ACB

Aurora Cannabis Inc.

https://www.auroramj.com

Industry

Drug Manufacturers - Specialty & Generic

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Open

5.09

Mkt cap

278M

Volume

1.4M

High

5.24

P/E Ratio

-11.31

52-wk high

9.35

Low

5.05

Div yield

N/A

52-wk low

2.84

The cannabis sector experienced a bullish sentiment on September 11, 2023, with several stocks closing up significantly. Green Growth Brands (OTC:GGBXF) led the gainers with a 900.00% increase, followed by Affinor Growers (OTC:RSSFF) and Canopy Gwth (NASDAQ:CGC) with 175.81% and 81.37% increases respectively. On the other hand, CLS Holdings USA (OTC:CLSH) led the losers with a 38.24% decrease.

Portfolio Pulse from Benzinga Insights

September 11, 2023 | 9:30 pm

Cannabis stocks are trading higher due to continued momentum amid US efforts to reschedule marijuana. Stocks mentioned include ACB, CLVR, CRON, GRWG, HITI, MSOS, OGI, SNDL.

Portfolio Pulse from Bill Haddad

September 11, 2023 | 6:14 pm

Aurora Cannabis Inc. has repurchased nearly $9 million of its convertible senior notes in multiple transactions to reduce debt and annual cash interest costs. This move is part of the company's goal to achieve positive free cash flow in 2024. The transactions will save Aurora more than $485 thousand in annualized interest payments. After the repurchases, Aurora will have approximately $39 million of convertible senior notes outstanding. The company's shares are trading higher following the announcement.

Portfolio Pulse from Erica Kollmann

September 11, 2023 | 2:24 pm

Aurora Cannabis Inc. has repurchased an aggregate of roughly CA$12.3 million ($9 million) principal amount of its convertible senior notes, reducing its debt and annual cash interest costs. The company aims to achieve positive free cash flow in 2024. Following these repurchases, Aurora will have approximately CA$53 million of notes outstanding. Aurora's shares traded 4.65% higher at $0.5536 per share during the pre-market session on Monday morning.

Portfolio Pulse from Jelena Martinovic

September 11, 2023 | 12:20 pm

The cannabis sector experienced significant movement on September 8, 2023. Notable gainers included Neptune Wellness Solns (NASDAQ:NEPT) with a 3732.62% increase, GreenGro Technologies (OTC:GRNH) up 38.89%, and Canopy Gwth (NASDAQ:CGC) up 22.61%. On the other hand, MPX International (OTC:MPXOF) shares dropped by 92.00%, AusCann Group Holdings (OTC:ACNNF) fell by 71.67%, and Corbus Pharmaceuticals (NASDAQ:CRBP) decreased by 4.25%.

Portfolio Pulse from Benzinga Insights

September 08, 2023 | 9:30 pm

Bipartisan talks over the Secure and Fair Enforcement (SAFE) Banking Act, a marijuana banking bill, have been productive during the August recess, according to the office of the lead GOP Senate sponsor. The legislation, which aims to protect banks and credit unions from being penalized by federal regulators for working with state-licensed cannabis businesses, could move to a vote soon. However, disagreements over one key section of the bill that some Democrats believe would undermine banking regulations could prevent it from advancing.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 2:55 pm

Senate Banking Committee Chairman Sherrod Brown plans to advance the Secure and Fair Enforcement (SAFE) Banking Act, a key marijuana banking legislation, within the next six weeks. The Act, which has bipartisan support, aims to protect banks and credit unions from federal penalties for working with state-licensed cannabis businesses. However, its passage is contingent on several factors, including disagreements over certain sections of the bill. The Act has 42 cosponsors, including eight Republicans and three independents, and is expected to reach the 60-vote threshold needed for passage in the Senate.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 3:15 pm

Aurora Cannabis Inc. (NASDAQ:ACB) is expanding its hemp-derived CBD portfolio into Brazil in partnership with Herbarium, a leading Brazilian company in herbal medicine. The CBD oil will be produced at Aurora's production facility in Uruguay and will be available under the direction of medical doctors across Brazil. Aurora's shares are trading higher amid the recent strong performance of the cannabis sector.

Portfolio Pulse from Jelena Martinovic

September 06, 2023 | 2:27 pm

Aurora Cannabis Inc. (NASDAQ:ACB) has announced a partnership with Brazilian company Herbarium to expand its hemp-derived CBD portfolio into Brazil. The company will launch its full-spectrum, single-source 3% CBD oil under the Herbarium brand, making it available to patients across Brazil under the direction of medical doctors.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 11:51 am

Aurora Cannabis Inc's shares are trading higher by roughly 3.4% amid the strong performance of the cannabis sector. This is due to the news that the Department of Health and Human Services (HHS) proposed reclassifying marijuana to a lower-risk drug category. The reclassification from Schedule I to Schedule III under the Controlled Substances Act is based on an FDA evaluation of marijuana's classification.

Portfolio Pulse from Henry Khederian

September 05, 2023 | 7:02 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.